Literature DB >> 27630304

GADD34 Promotes Tumor Growth by Inducing Myeloid-derived Suppressor Cells.

Lintao Liu1, Sachiko Ito2, Naomi Nishio2, Yang Sun2, Yuriko Tanaka2, Ken-Ichi Isobe2.   

Abstract

BACKGROUND: Tumor hypoxia induces the expression of growth arrest and DNA damage-inducible protein (GADD34). However, the role of GADD34 in tumor growth remains unclear.
MATERIALS AND METHODS: Gadd34 expression was knocked-down through lentivirus-mediated short hairpin RNA (shRNA) in tumor cells, which were subsequently injected subcutaneously into mice. Tumor volumes and myeloid-derived suppressor cells (MDSCs) were monitored. Isolated MDSCs were incubated with tumor supernatant to investigate the impact of GADD34 on cytokine secretion of MDSCs.
RESULTS: We observed that reduction of GADD34 expression significantly suppressed tumor, and resulted in decreased accumulation of MDSCs and T-cells, and inhibition of GADD34 reduced secretion of vascular epithelial growth factor α and transforming growth factor β by MDSCs.
CONCLUSION: These findings provide a promising strategy for targeting GADD34 activity in order to inhibit tumor growth. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  GADD34; Gr1+CD11b+ MDSC; Lewis lung carcinoma; TGFβ; VEGFA

Mesh:

Substances:

Year:  2016        PMID: 27630304     DOI: 10.21873/anticanres.11012

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.

Authors:  Peiying Song; Songpeng Yang; Hui Hua; Hongying Zhang; Qingbin Kong; Jiao Wang; Ting Luo; Yangfu Jiang
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

2.  In Vitro and In Vivo Comparative Analysis of Differentially Expressed Genes and Signaling Pathways in Breast Cancer Cells on Interaction with Mesenchymal Stem Cells.

Authors:  Hariharan Jayaraman; Ashwin Anandhapadman; Nalinkanth Veerabadran Ghone
Journal:  Appl Biochem Biotechnol       Date:  2022-09-10       Impact factor: 3.094

3.  Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis.

Authors:  Yujie Lei; Yunchao Huang; Jianbin Lin; Shihui Sun; Keda Che; Junting Shen; Jun Liao; Yangming Chen; Kai Chen; Zhaoxian Lin; Xing Lin
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.